OTC : BMCS

BioTech Medics, Inc.

$0.001 USD

$0 (0.0%)

Volume
500
Average Volume
12.01K
Market Capitalization
$205.36K
P/E Ratio
-69.32
Dividend Yield
0.00%
Price Target
Year High
$0.01
Year Low
$0.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.00
Company Overview

OTC

Anthony Keith Miller

Drug Manufacturers - Specialty & Generic

Healthcare

BMCS

0

US

USD

972-274-5533

090699307

0001384066

Liquidity Metrics

0.00

0.00

0.00

0.00

0.00

Sales & Valuation

-$

0.00

0.00

-7.63

0.00

Profitability

$0

-$2919

0.00%

0.00%

0.00%

0.00%

P/E Metrics

-69.32

0.23

0.23

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

0.25

3/9

-$441.44K

$100M

$441.14K

$6250.0

Key Metrics (TTM)

$207.36K

0.00

-71.04

0.00

0.00%

0.00%

-1.44%

-13.10%

0 days

Company Executives
Name Title
Tom Wood Senior Vice President of Sales
James C. Nairne Chief Financial Officer
Keith A. Houser Chairman & Interim President
Anthony Keith Miller Chief Executive Officer
Poll Results

No votes yet today — be the first to share your view!

About BioTech Medics, Inc. (OTC:BMCS) Stock

BioTech Medics, Inc. operates as a holding company with a focus on the medical field. The firm manages therapeutic laser clinics that deliver treatment for diverse pain conditions impacting muscles, nerves, bones, and arthritic discomfort. Among its product offerings is SHBAN, an antiseptic sanitizing solution for hands and body. Additionally, the company develops and markets nutritional supplements, including BioBody Balance, a concentrated liquid vitamin, and BioBody Energy Spray, a natural, caffeine- and alcohol-free vitamin energy spray. These nutraceutical products are distributed via general retail channels. Founded in 1997 and headquartered in Southlake, Texas, BioTech Medics maintains laser pain centers across Texas, California, New Mexico, and Florida. ...

Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success

2026-06-10 07:38:00

Artelo's lead medicinal chemist reveals findings at the Royal Society of Chemistry-BMCS/DMDG Medicinal Chemistry Conference in London Artelo's lead medicinal chemist reveals findings at the Royal Society of Chemistry-BMCS/DMDG Medicinal Chemistry Conference in London

Frequently Asked Questions

What is the current BioTech Medics, Inc. (BMCS) stock price?

BioTech Medics, Inc.(OTC:BMCS) stock price is $0.001 in the last trading session. During the trading session, BMCS stock reached the peak price of $0.014 while $0.0001 was the lowest point it dropped to. The percentage change in BMCS stock occurred in the recent session was 0.0% while the dollar amount for the price change in BMCS stock was $0.

BMCS's industry and sector of operation?

The OTC listed BMCS is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of BMCS?

Tom Wood | Senior Vice President of Sales
James C. Nairne | Chief Financial Officer
Keith A. Houser | Chairman & Interim President
Anthony Keith Miller | Chief Executive Officer
|

How many employees does BMCS have?

Number of BMCS employees currently stands at 0. BMCS operates from PO Box 93476, Southlake, TX 76092-0114, US.

Link for BMCS official website?

Official Website of BMCS is: https://biotecmedics.com

How do I contact BMCS?

BMCS could be contacted at phone #972-274-5533 and can also be accessed through its website. BMCS operates from PO Box 93476, Southlake, TX 76092-0114, US.

How many shares of BMCS are traded daily?

The average number of BMCS shares traded daily for last 3 months was 12.01K.

What is the market cap of BMCS currently?

The market value of BMCS currently stands at $205.36K with its latest stock price at $0.001